Completed PHASE2 INTERVENTIONAL 2-arm NCT01534390

Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients

The Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients: A Prospective, Randomized, Controlled Trial

Sponsor: University of Salzburg

Conditions Systemic Inflammation

Interventions In-line microfilter (Supor IV Filter; Pall Corporation, Port Washington, New York)

Updated 5 times since 2017 Last updated: May 31, 2015 Started: Apr 30, 2012 Primary completion: Apr 30, 2013 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Systemic Inflammation, this trial is completed. The trial is conducted by University of Salzburg and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Salzburg

Data source: University of Salzburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salzburg, Austria